Atlas Trials

Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus

Clinical trial NCT01677013 · COMPLETED

Trial details

NCT number
NCT01677013
Sponsor
Peking University Aerospace Center Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2011-05-01
Primary completion
2015-05-01
Enrollment
1026

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.